Detalles de la búsqueda
1.
The role of the caregiver in older patients with advanced prostate cancer: results from the ADHERE Prospective Study of the Meet-URO network.
Support Care Cancer
; 31(7): 425, 2023 Jun 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37358628
2.
Pembrolizumab Plus Axitinib for Metastatic Papillary and Chromophobe Renal Cell Carcinoma: NEMESIA (Non Clear MEtaStatic Renal Cell Carcinoma Pembrolizumab Axitinib) Study, a Subgroup Analysis of I-RARE Observational Study (Meet-URO 23a).
Int J Mol Sci
; 24(2)2023 Jan 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36674615
3.
Adherence to Oral Treatments in Older Patients with Advanced Prostate Cancer, the ADHERE Study: A Prospective Trial of the Meet-URO Network.
Oncologist
; 27(12): e949-e956, 2022 Dec 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920559
4.
The prognostic value of the previous nephrectomy in pretreated metastatic renal cell carcinoma receiving immunotherapy: a sub-analysis of the Meet-URO 15 study.
J Transl Med
; 20(1): 435, 2022 09 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-36180954
5.
Safety and Efficacy of Tivozanib in First-Line mRCC: A Multicenter Compassionate-Use Study (Meet-Uro 16).
Oncology
; 99(12): 747-755, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34583356
6.
Eribulin Mesylate as Third or Subsequent Line Chemotherapy for Elderly Patients with Locally Recurrent or Metastatic Breast Cancer: A Multicentric Observational Study of GIOGer (Italian Group of Geriatric Oncology)-ERIBE.
Oncologist
; 24(6): e232-e240, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413667
7.
Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program.
Future Oncol
; 14(26): 2691-2699, 2018 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-30207488
8.
Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer.
Future Oncol
; 12(4): 493-502, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26776493
9.
Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education Initiatives.
J Cancer Educ
; 31(2): 405-12, 2016 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25773134
10.
Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.
Prostate
; 75(12): 1329-38, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25982919
11.
Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme.
BJU Int
; 115(5): 764-71, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24988879
12.
Intermittent docetaxel chemotherapy as first-line treatment for metastatic castration-resistant prostate cancer patients.
Future Oncol
; 11(6): 965-73, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25760977
13.
Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.
Future Oncol
; 11(21): 2881-91, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-26436290
14.
Metabolomics biomarkers of frailty in elderly breast cancer patients.
J Cell Physiol
; 229(7): 898-902, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24659054
15.
Real-world cabazitaxel safety: the Italian early-access program in metastatic castration-resistant prostate cancer.
Future Oncol
; 10(6): 975-83, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24295376
16.
Prognostic Stratification by the Meet-URO Score in Real-World Older Patients With Metastatic Renal Cell Carcinoma (mRCC) Receiving Cabozantinib: A Subanalysis of the Prospective ZEBRA Study (Meet-URO 9).
Clin Genitourin Cancer
; 22(2): 126-133.e2, 2024 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932204
17.
A phase II study evaluating the efficacy of enzalutamide and the role of liquid biopsy for evaluation of ARv7 in mCRPC patients with measurable metastases including visceral disease (Excalibur study).
Ther Adv Med Oncol
; 16: 17588359231217958, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38264520
18.
Instrumental activities of daily living in older patients with metastatic prostate cancer: results from the meet-URO network ADHERE prospective study.
Sci Rep
; 14(1): 4949, 2024 02 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38418470
19.
Initial management approach for localized/locally advanced disease is critical to guide metastatic castration-resistant prostate cancer care.
Prostate Cancer Prostatic Dis
; 2024 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38347113
20.
Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study.
Front Oncol
; 14: 1307635, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38410103